Peptide receptor radionuclide therapy and theranostics beyond neuroendocrine tumors and into the next decade

被引：0
|
作者：
Satz, S. [1 ]
Baum, R. P. [2 ]
Sathekge, M. M. [3 ,4 ]
机构：
[1] Adv Imaging Projects LLC, Lake Worth, FL USA
[2] Zent Klin, Bad Berka, Germany
[3] Univ Pretoria, ZA-0002 Pretoria, South Africa
[4] Steve Biko Acad Hosp, Pretoria, South Africa
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
68
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [22] Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
    Hope, Thomas A.
    Pavel, Marianne
    Bergsland, Emily K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (24) : 2818 - +
  • [23] Addendum to the Editorial "Joint Guidance on Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors"
    Delbeke, Dominique
    Graham, Michael M.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (07) : 1170 - 1170
  • [24] The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
    Bodei, Lisa
    Cwikla, Jaroslaw B.
    Kidd, Mark
    Modlin, Irvin M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1511 - S1523
  • [25] Tumor Cystic Necrosis Following Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Ladwa, Rahul
    Wen Hong, Hooi
    Wyld, David
    Pattison, David A.
    Burge, Matthew
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) : 186 - 187
  • [26] Quality Of Life in Patients with Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy
    Wang, Q.
    Librizzi, D.
    Bagheri, S.
    Ebrahimifard, A.
    Luster, M.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S246 - S247
  • [27] Emergence of clonal hematopoiesis after peptide receptor radionuclide therapy for neuroendocrine tumors
    El Ferkh, R.
    Hadoux, J.
    Lamartina, L.
    Kamoun, T.
    Cysique-Foinlan, L.
    Jepiral, G.
    Ducreux, M. P.
    Baudin, E.
    Marzac, C.
    Micol, J. Baptiste
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S954 - S955
  • [28] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: how important is internal dosimetry?
    Trauernicht, Christoph
    du Toit, Pieter
    SOUTH AFRICAN JOURNAL OF SURGERY, 2019, 57 (01) : 57 - 57
  • [29] Evaluation of Toxicity in Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumors (NET)
    Duan, H.
    Girod, B.
    Ninatti, G.
    Ferri, V
    Kunz, P.
    Fisher, G.
    Moradi, F.
    Davidzon, G.
    Franc, B.
    Lagaru, A.
    Aparici, Mari C.
    NEUROENDOCRINOLOGY, 2020, 110 : 252 - 252
  • [30] Evaluation of toxicity in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P. L.
    Fisher, G. A.
    Moradi, F.
    Davidzon, G. A.
    Franc, B. L.
    Iagaru, A. H.
    Mari, C. Aparici
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S471 - S472
12345